Jacob Duncan – Research output — OSU Center for Health Sciences Research Profiles

Research activity per year

9 Poster

9 results

Filter

2024
Assessing the Cost-Saving Potential of the Mark Cuban Cost Plus Drug Company for Diabetes Medications: A Comparative Study with Medicare Part D Pricing
Oldham, E., Hall, R. H., Duncan, J., Rashid, M., Modi, J., Magee, T., Fitzgerald, K. & Vassar, M., 16 Feb 2024, p. 74.
Research output: Contribution to conference › Poster › peer-review

Open Access
Exploring Affordable Solutions for Orthopedic Medications: A Comparative Study of Mark Cuban Cost Plus Drug Company (MCCPDC) and Medicare
Young, A., Jelinek, T., Smith, T., Elfar, A., Rashid, M., Duncan, J., Checketts, J. X., Anderson, M. & Vassar, M., 16 Feb 2024, p. 110.
Research output: Contribution to conference › Poster › peer-review

Open Access
Exploring Clinical Trialists Perspectives on Core Outcome Sets in Anxiety Trials: A Web-Based Survey Study
Sims, S., Varughese, N., Hall, E. H., Barks, N., Duncan, J., Elfar, A., Chaudhry, A., Cox, K., Ernst, Z., Hughes, G. & Vassar, M., 16 Feb 2024, p. 92.
Research output: Contribution to conference › Poster › peer-review

Open Access
Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model
Smith, T., Young, A., Duncan, J., Rashid, M., O'Brien, C., Magee, T., Fitzgerald, K. & Vassar, M., 16 Feb 2024, p. 96.
Research output: Contribution to conference › Poster › peer-review

Open Access
Potential Medicare and Medicaid Savings for Hair and Skin Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model
Gardner, T., Hagood, A., Modi, J., Jones, G., Duncan, J., Rashid, M. & Vassar, M., 16 Feb 2024, p. 34.
Research output: Contribution to conference › Poster › peer-review

Open Access
Reducing Men's Health Drug Costs: Exploring the Impact of the Mark Cuban Cost Plus Drug Company Model on Medicare Savings
Khan, A., Kari, K., Elfar, A., Oldham, E., Duncan, J., Rashid, M. & Vassar, M., 3 Feb 2024.
Research output: Contribution to conference › Poster › peer-review

File

27 Downloads (Pure)
2023
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials
Jhanji, V., Duncan, J., Gardner, T., Hughes, G. K., McIntire, R., Peña, A., Ladd, C., Gardner, B., Moore, T., Garrett, E., Cook, C., Tuia, J., Haslam, A., Prasad, V. & Vassar, M., 21 Jul 2023.
Research output: Contribution to conference › Poster › peer-review

Open Access
File
15 Downloads (Pure)
Evaluation of Adherence to Reporting Guidelines Among Geriatric Journals: A Meta-Epidemiological Study
Corwin, L., Duncan, J., Ward, S., Smith, C., Brewer, D. & Vassar, M., 3 Mar 2023, p. 14.
Research output: Contribution to conference › Poster › peer-review
Reducing Men's Health Drug Costs: Exploring the Impact of the Mark Cuban Cost Plus Drug Company Model on Medicare Savings
Khan, A., Kari, K., Elfar, A., Oldham, E., Duncan, J., Rashid, M. & Vassar, M., 15 Sep 2023.
Research output: Contribution to conference › Poster › peer-review

Open Access
File

21 Downloads (Pure)